| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AMGN | Common Stock | Award | $0 | +6,792 | +9.5% | $0.000000 | 78,338 | 03 Mar 2025 | Direct | F1 |
| holding | AMGN | Common Stock | 876 | 03 Mar 2025 | 401K Plan | F2 |
| Id | Content |
|---|---|
| F1 | These shares include 667 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. |
| F2 | These shares are acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing. |